Skip to main content
Clinical Trials/NCT04806152
NCT04806152
Terminated
Not Applicable

Effect of Exercise on Muscle Mass, Functional Capacity and Physical Activity in Community-dwelling Elderly With Sarcopenia in Jamaica

The University of The West Indies1 site in 1 country38 target enrollmentMay 2, 2017
ConditionsSarcopenia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
The University of The West Indies
Enrollment
38
Locations
1
Primary Endpoint
Lower extremity (LE) functional strength
Status
Terminated
Last Updated
5 years ago

Overview

Brief Summary

This study examined the effects of combined-modality exercise training (resistance, endurance, flexibility and balance) on muscle mass, muscle function and physical activity in community-dwelling elderly living in Jamaica who had been characterised as having sarcopenia.

Detailed Description

Community-dwelling seniors aged 60 years and older were screened for muscle mass and function (grip strength and walk speed) and persons with sarcopenia were identified using the European Working Group on Sarcopenia in Older Persons (EWGSOP) algorithm for case finding (N=1344). Of the 77 seniors with sarcopenia, 38 consented to participate and were randomly allocated to receive 6 months combined-modality high intensity treadmill based exercise and a 'usual care' home exercise programme. A comparison of the effects of treatment assignment on muscle mass, function, fitness, physical activity level and disability was done. Participants in the supervised combined-modality high intensity group were required to attend sessions 3 times per week; participants in the home exercise programme were required to attend 1 supervised session at the start of their 6-month intervention. Outcomes were assessed at baseline and at the end of the 6-month intervention. Data were analysed using standard statistical parametric and non-parametric methods including repeated measures analysis of variance to determine changes in outcomes and regression to establish determinants of outcomes.

Registry
clinicaltrials.gov
Start Date
May 2, 2017
End Date
March 20, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Factorial
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • over 60 years old,
  • independently ambulant, with or without an assistive device
  • mentally competent to give informed consent and follow exercise instructions

Exclusion Criteria

  • a history of stroke with residual disability
  • a diagnosis of cancer
  • neuromuscular disorders
  • auto-immune disorders
  • severe arthritis rendering participation in an exercise programme difficult
  • unstable cardiovascular disease which renders exercise unsafe

Outcomes

Primary Outcomes

Lower extremity (LE) functional strength

Time Frame: 6 months

1-repetition maximum (RM) strength

Appendicular lean mass index

Time Frame: 6 months

dual energy x-ray absorptiometry (DEXA) measured appendicular lean mass summed and divided by height squared, expressed in kg/m2

Functional endurance

Time Frame: 6 months

Distance walked in 6 minutes

Disability

Time Frame: 6 months

Lawton Instrumental Activities of Daily Living scale: minimum score = 0 (low function, dependent); maximum score = 8 (high function, independent). Lower scores indicate a worse outcome.

Fat-free mass

Time Frame: 6 months

dual energy x-ray absorptiometry (DEXA) determined: fat mass subtracted from weight, expressed in kg

self-selected walk speed

Time Frame: 6 months

speed in the timed-10-metre walk

Accelerometry

Time Frame: 6 months

weekly energy expenditure

Balance

Time Frame: 6 months

Berg balance test score: minimum score = 0, maximum score = 56. Lower values indicate worse outcome

Secondary Outcomes

  • Depression(6 months)
  • Timed-up-and-go(6 months)

Study Sites (1)

Loading locations...

Similar Trials